# ## ## ## |||||Page| |---|---|---|---|---| |Reference and administrative||details ofthe Company,|its Trustees and advisers|1-2| |Chairman's|statement|||3-4| |Trustees'
report||||5-22| |Independent|auditor's
report|on the financial statements||23-26| |Consolidated|statement
of financial activities|||27| |Consolidated|balance sheet|||28| |Company balance sheet||||29| |Consolidated|statement
ofcash flows|||30| |Notes to the|financial statements|||31 —54| ## ## |Trustees|Jonathan
Trower,|Chairman|Chairman||||| |---|---|---|---|---|---|---|---| ||Darren Hayward||||||| ||Annalisa
Ridsdill|Smith|||||| ||Dr Famzi Freij||||||| ||Clive Gilham||||||| ||Roy Marflest||||||| ||Claire Smith||||||| ||Andrew
Tunningley||||||| ||Ellisa Estrin||||||| ||Michelle Tennens||||||| |Company registered|||||||| |number|05397840||||||| |Charity registered|||||||| |number|1108989||||||| |Registered office|Flight House, The Business Centre,||||Earls Colne Business Park||| ||Earls Colne||||||| ||Colchester||||||| ||Essex||||||| ||CO6 2NS||||||| |Website address|www. ehaat. org||||||| |Company secretary|Brenda Playford||||||| |Executive Team|Jane Gurney —Chief Executive Officer||||||| ||Dr Neal Durge —Medical Director (until 19/01/23)||||||| ||Dr Gareth Davies|—Senior Medical|||Advisor (appointed||12/06/23)| ||Dr Tony Joy —Interim||Medical|Director (appointed||12/06/23)|| ||Dr Peter Sherren|—Assistant||Medical Director (until||31/12/22)|| ||Cliff Gale —Operations||Director (Retired 31/12/22)||||| ||Pam Withrington|—Fundraising||and|Marketing
Director||| ||Jonathan
Ager —Finance Director||||||| ||Paul Curtis —Aviation||&Operations||Director (appointed||23/05/22)| |Independentauditor|Crowe U.K.LLP||||||| ||Riverside
House||||||| ||40 - 46 High Street||||||| ||Maidstone||||||| ||Kent||||||| ||ME141JH||||||| |Bankers|Barclays Bank Pic||||||| ||40 High Street||||||| ||Chelmsford||||||| ||Essex||||||| ||CM1
1 BE||||||| ## ## ## ## ## ## ## ||Committee/Group||||||||Trustees|Trustees||| |---|---|---|---|---|---|---|---|---|---|---|---|---| |Investment|Advisory
Committee|(established|||Nov|Andrew|Tunningley||(Chair), Jonathan||Trower, Clive|| |14)||||||ilham||||||| |Audit and Risk Committee
(established||||Sept|19)|Clive Gilham||(Chair), Andrew||Tunningley,||Michelle| |||||||ennens||||||| |Nominations|Committee
(established||Nov '20)|||Darren|Hayward
(Chair), Jonathan
Trower,|||||Annalisa| |||||||Ridsdill|Smith|||||| |Retail Advisory
Committee
(established||||Sept|'20)|Claire Smith||(Chair),|Annalisa|Ridsdill|Smith, Roy|| |||||||Marflect||||||| |Clinical Committee
(established||May '22)||||Ramzi Freij (Chair),|||Jonathan|Trower,|Ellisa Estrin|| ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ||||Restricted|Unrestricted|Total|Total| |---|---|---|---|---|---|---| ||||funds|funds|funds|funds| |||Note|2023
2|2023
2|2023
2|2022f| |Income from:||||||| |Donations
and legacies|||38,458|6,079,756|6,118,214|4,565,960| |Charitable
activities|||35,940|57,172|93,112|105,601| |Other trading
activities|||2,085,425|8,713,345|10,798,770|10,512,847| |Investments||||618,722|618,722|334,065| |Total income|||2,159,823|15,468,995|17,628,818|15,518,474| |Expenditure
on:||||||| |Raising funds|||419,509|4,712,394|5,131,903|4,932,172| |Charitable
activities|||2,558,019|6,261,300|818195319|7,205,321| |Total expenditure|||2,977,528|10,973,694|13,951,222|12,137,493| |Operating
surplus|||(817,705)|4,495,301|3,677,596|3,380,961| |Net (losses)/gains|on investments|||(1,214,487)|(1,214,487)|620,655| |Net (expenditure)/income|||(817,705)|3,280,814|2,463,109|4,001,636| |Transfers between|funds|18|(12,995)|12,995||| |Net movement
in|funds||(830,700)|3,293,809|2,463,109|4,001,636| |Reconciliation
of|funds:|||||| |Total funds brought|forward||876,132|43,542,373|44,418,505|40,416,869| |Net movement
in funds|||(830,700)|3,293,809|2,463,109|4,001,635| |Total funds carried forward|||45,432|46,836,182|46,881,614|44,418,505| ## ||CONSOLIDATED|BALANCE SHEET||| |---|---|---|---|---| ||ASAT 31|MARCH 2023||| |||2023||2022| ||Note|2||| |Fixed assets||||| |Intangible assets|12|3,192||11,734| |Tangible assets|13|19,303,726||11,026,987| |Investments|14|32,437,175||31,928,373| |||51,744,093||42,957094| |Current assets||||| |Stocks|15|16,809|29,727|| |Debtors|16|1,971,645|1,093,407|| |Cash at bank and in hand||3,901,303|2,728,805|| |||5,889,757|3,851,939|| |Creditors: amounts|falling due within one|||| |year|17|(10,752,235)|(2,400,528)|| |Net current liabilities Iassets||(4,862,478)||1,451,411| |Total net assets||46,881,615||44,418,505| |Charity funds||||| |Restricted funds|18|45,432||876,132| |Unrestricted
funds|18|46,836,183||43,542,373| |Total funds||46,881,615||44,418,505| ## |||COMPANY|BALANCE SHEET||| |---|---|---|---|---|---| |||AS AT31 IIIIARCH 2023|||| |||Note|2023
2||2022f| |Fixed assets|||||| |Intangible assets||12|3,192||11,734| |Tangible assets||13|19,303,726||11,026,987| |Investments||14|32,437,179||31,928,377| ||||51,744,097||42,957,098| |Current assets|||||| |Stocks||15|16,809|29,727|| |Debtors||16|4,204,114|2,308,755|| |Cash at bank and|in hand||1,086,272|1,142,255|| ||||5,307,195|3,4BO,737|| |Creditors: amounts|falling dus within one||||| |year||17|(10,169,677)|(2,029,330)|| |Net current liabilities )assets|||(4,862,482)||1,451,407| |Total net assets|||46,881,615||44,41B,505| |Charity funds|||||| |Restricted funds||18|45,432||876,132| |Unrestricted
funds||18|46,836,183||43,542,373| |Total funds|||46,881,615||44,418,505| ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## |Long-term
leasehold|property||| |---|---|---|---| |Short-term
leasehold|property|Straight
line over|the length of the lease| |Helicopter||20 years straight|line| |Motor vehicles||2-4 years straight|line| |Fixtures and fittings|and|2-4 years straight|line| |computer
equipment|||| |Assets under construction||Nil|| |Clinical equipment||3-4 years straight|line| ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ||Restricted|Unrestricted|Total| |---|---|---|---| ||funds|funds|funds| ||2023|2023|2023| ||2|6|2| |Donations|36,456|1,741,678|1,780,336| |Legacies||3,371,274|3,3715274| |In-memoria||355,592|355,592| |Collection Tins||90,500|90,500| |Donated services||520,512|520,512| ||36,456|6,079,756|6,118,214| ||Restricted|Unrestricted|Total| ||funds|funds|funds| ||2022
f|2022
f|2022| |Donations|38,774|1,329,480|1,368,254| |Legacies||2,325,985|2325,985| |In-memoria||310,111|310,111| |Collection Tins||88,930|88,930| |Donated services||472,680|472680| ||38,774|4,527,186|4,565,960| |5.|Income from|charitable|activities|||| |---|---|---|---|---|---|---| |||||Restricted|Unrestricted|Total| |||||funds|funds|funds| |||||2023|2023|2023| |||||2|2|2| ||Grant-making|trusts||35,940|57,172|93,112| ## ## ## ## ## ## ## |Restricted|Unrestricted|Total| |---|---|---| |funds|funds|funds| |2022|2022|2022| |18,353|87,248|105,601| ## |||Restricted|Unrestricted|Total| |---|---|---|---|---| |||funds|funds|funds| |||2023|2023|2023| |||2||2| |Income from|lottery|2,085,425|7,581,120|9,666,545| |Fundraising|events||159,128|159,128| |Merchandise|sales||22,307|22,307| |Charity shop|income||949,290|949,290| |Other|||1,500|1,500| |||2,085,425|8,713,345|10,798,770| |||Restricted|Unrestricted|Total| |||funds|funds|funds| |||2022|2022|2022f| |Income from|lottery|9,666,594||9,666,594| |Fundraising|events||122,150|122,150| |Merchandise|sales||14,332|14,332| |Charity shop|income||709,771|709,771| |||9,866,594|846,253|10,512,847| ## ## ## ## ||Unrestricted|Total| |---|---|---| ||funds|funds| ||2023|2023| ||2|2| |Dividends|616,583|616,583| |Interest|2,139|2,139| ||618,722|618,722| ||Unrestricted|Total| ||funds|funds| ||2022|2022| |Dividends|334,066|334,066| |8.|Analysis|ofexpenditure|ofexpenditure|by activities|||| |---|---|---|---|---|---|---|---| ||||||Activities||| ||||||undertaken|Support|Total| ||||||directly|costs|funds| ||||||2023f|2023
2|2023
2| ||Helicopter|Emergency|Medical Service||7,621,234|998,085|8,819,319| ||||||Activities||| ||||||undertaken|Support|Totai| ||||||directly|costs|funds| ||||||2022|2022f|2022| ||Helicopter|Emergency|Medical Service||6,506,161|699,140|7,205,321| ## ## ## ## ## ||Total|Total| |---|---|---| ||funds|funds| ||2023|2022| ||2|| |Depreciation|828,448|702,809| |Helicopter and Rapid Response Vehicle|3,743,268|2,852,196| |Clinical costs|2,712,878|2,576,636| |Airbase premises costs|398,818|374,540| |Centre for Excellence|137,821|| |Total 2023|7,821,233|6,506,181| ## ## ||||Total|Total| |---|---|---|---|---| ||||funds|funds| ||||2023|2022| ||||2|| ||Staff costs||787,442|531,900| ||Operations
and support costs||101,021|96,998| ||Other employment|costs|90,714|53,470| ||Governance
costs||18,909|16,772| ||||998,086|699,140| |9.|Governance costs|||| ||||2023|2022| ||||2|| ||Auditors'
remuneration||32,000|28,500| ||Trustees meetings||893|2,147| ||Trustee indemnity|insurance|1,962|1,962| ||Legal, consultancy|and other fees|(706)|(768)| ## ## ## |Staff cost|s||||||||| |---|---|---|---|---|---|---|---|---|---| ||||||Group||Group|Company|Company| ||||||2023
8||2022|2023
2|2022
f| |Wages and||salaries|||2,452,828||1,769,694|2,452,828|1,789,694| |Social security costs|||||246,398||172,764|246,398|172,764| |Contribution||to defined|contribution|pension|||||| |schemes|||||140,602||110,508|140,602|110,506| ||||||2,839,828|2072,966||2,839,828|2072,966| |The average||number|of persons employed||by the Company
during||the year was as follows:||| |||||||||Group|Group| |||||||||2023|2022| |||||||||No.|No.| |Charitable|activities|||||||12|6| |Raising funds||||||||31|26| |Lottery||||||||3|3| |Retail||||||||26|25| |||||||||72|64| |Group|Group| |---|---| |2023|2022| |No.|No.| ## ## ## ## ## ## ||Computer| |---|---| ||software| ||2| |Cost|| |At 1 April 2022|115,893| |At 31 March 2023|115,893| |Amortisation|| |At 1 April 2022|104,159| |Charge for the year|8,542| |At 31 March 2023|112,701| |Net book value|| |At 31 March 2023|3,192| |At31March 2022|11,734| ## ## ## ||Long-term|||||| |---|---|---|---|---|---|---| ||leasehold|Plant and|Motor|Fixtures|Other fixed|| ||property
2|machinery
2|vehicles
2|and fittings
2|assets
2|Total
2| |Cost or valuation||||||| |At 1 April 2022|5,569,969|7,055,314|433,268|458,136|650,793|14,167,480| |Additions|278,662|8,649,421||235,036||9,163,119| |At 31 March 2023|5,848,631|15,704,735|433,268|693,172|650,793|23,330,599| |Depreciation||||||| |At 1 April 2022|593,687|1,627,324|294)294|200,245|424,943|3,140,493| |Charge for the year|254,033|354,023|57,256|135,699|85,369|886,380| |At 31 March 2023|847,720|1,981,347|351,550|335,944|510,312|4,026,873| |Net book value||||||| |At 31 March 2023|5,000,911|13,723,388|81,718|357,228|140,481|19,303,726| |At31March 2022|4,976,282|5,427,990|138,974|257,891|225,850|11,026,987| ## ## ## ## |||Listed| |---|---|---| |||investments| |Group||2| |Cost or valuation||| |At 1 April 2022||31,828,373| |Additions||16,648,441| |Disposals||(16,084,537)| |Revaluations||(763,314)| |Dividends
retained||520,446| |Foreign exchange|movement|187,766| |At 31 March 2023||32,437,175| |Net book value||| |At 31 March 2023||32,437,175| |At 31March 2022||31,929,373| ## ## ||||||Investments|||| |---|---|---|---|---|---|---|---|---| ||||||In|||| ||||||subsidiary||Listed|| ||||||companies||investments|Total| ||Company|||||2|2|2| ||Cost or valuation|||||||| ||At 1 April|2022||||4|31,928,373|31,928,377| ||Additions||||||16)648)441|16,648,441| ||Disposals||||||(16,084,537)|(16,084,537)| ||Revaluations||||||(763,314)|(763,314)| ||Dividends|retained|||||520,446|520,446| ||Foreign exchange||movement||||187,766|187,766| ||At 31 March 2023|||||4|32,437,175|32,437,179| ||Net book|value||||||| ||At 31 March 2023|||||4|32,437,175|32,437,179| ||At 31March 2022|||||4|31,928,373|31,928,377| |15.|Stocks|||||||| |||||Group|Group||Company|Company| |||||2023|2022||2023|2022| |||||6|||6|| ||Finished|goods and goods for resale||16,809|29,727||16,809|29,727| ## ## ## ## |||||Group|Group|Company|Company| |---|---|---|---|---|---|---|---| |||||2023|2022|2023|2022| |||||6||6|| |Due within one year|||||||| |Trade debtors||||4,067|8,290|4,067|8,290| |Amounts
owed by group undertakings||||||2,255,865|1,246,568| |Other debtors||||716|694|510|4SO| |Prepayments
and accrued income||||278,922|341,367|2555732|310,381| |Tax recoverable||||106,332|115,410|106,332|115,410| |Legacy Debtor||||1,581,608|S27,646|1,581,608|627,646| |||||1,971,645|1,093,407|4,204,114|2,308,755| |Creditors: Amounts||falling due|within one year||||| |||||Group|Group|Company|Company| |||||2023|2022|2023|2022| |||||2||6|| |Trade creditors||||618,187|357,446|619,515|344,008| |Amounts
owed to group undertakings|||||||213,398| |Other taxation and social security||||71,442|48,516|71,442|48,516| |Other creditors||||560,804|538,209|3,673|2879| |Accruals and deferred||income||9,501,802|1,456,357|9,475,047|1,420,529| |||||10,752,235|2400,528|10,169,677|2,029,330| |||||||Group|Group| |||||||2023|2022| |||||||6|| |Deferred income at|1|April 2022||||506,836|479,095| |Resources deferred|during the year|||||516,360|506,836| |Amounts
released from previous|||periods|||(506,836)|(479,095)| |||||||516,360|506,836| ## |18.|Statement||offunds||||||| |---|---|---|---|---|---|---|---|---|---| ||Statement||offunds|- current year|||||| ||||||||||Balance at| ||||Balance at 1||||Transfers|Gains/|31 March| |||||April 2022|Income|Expenditure|in/out|(Losses)|2023| |||||2|2|2|2|2|2| ||Unrestricted||||||||| ||funds||||||||| ||Designated||||||||| ||funds||||||||| ||Fixed asset||lund|11,038,721||(894,922)|9,163,119||19,306,918| ||Helicopter|fund||7,200,000|||(7,200,000)||| ||Centre of||||||||| ||excellence|||1,000,000||(137,821)|||862,179| ||Designation||for||||||| ||expendable||||||||| ||endowment||||||5,000,000||5,000,000| |||||19,238,721||(1,032,743)|6,963,119||25,169,097| ||General funds||||||||| ||General Funds-||||||||| ||all funds|||24,303,652|15,468,996|(9,940,951)|(6,950,124)|(1,214,487)|21,667,086| ||Total||||||||| ||Unrestricted||||||||| ||funds|||43,542,373|15,468,996|(10,973,694)|12,995|(1,214,487)|46,836,183| ||Restricted||||||||| ||funds||||||||| ||Restricted|Fund||876,132|2,159,823|(2,977,528)|(12,995)||45,432| ||Total offunds|||44,418,505|17,628,819|(13,951,222)||(1,214,487)|46,881,615| ## ## ## ## ## |Statement|offun|ds - prior year|||||| |---|---|---|---|---|---|---|---| ||||||||Balance at| |||Balance at|||Transfers|Gainer|31March| |||1April 2021|Income
f|Expenditure|infout|(Losses)|2022| |Unrestricted|||||||| |funds|||||||| |Designated|||||||| |funds|||||||| |Fixed asset fund||11,012,200||(772,153)|798,674||11,038,721| |Helicopter|fund||||7,200,000||7,200,000| |Centre of|||||||| |excellence|||||1,000,000||1,000,000| |||11,012,200||(772,153)|8,998,674||19,238,721| |Generalfunds|||||||| |General Funds-|||||||| |all funds||27,779,586|5,794,753|(1,487,992)|(8,403,350)|620,655|24,303,652| |Total|||||||| |Unrestricted|||||||| |funds||38,791,786|5,794,753|(2280,145)|595,324|620,655|43,542373| |Restricted|||||||| |funds|||||||| |Restricted|Fund|1,625,083|9,723,721|(9,877,348)|(595,324)||876,132| |Total offunds||40,416,869|15,518,474|(12,1374g3)||620,655|44,418,505| ## ## ## ## |Analysis
Analysis|of net assets between funds
of net assets between funds - current year|||| |---|---|---|---|---| |||Restricted|Unrestricted|Total| |||funds|funds|funds| |||2023|2023|2023| |||2|2|6| |Tangible|fixed assets||19,303,726|19,303,726| |Intangible|fixed assets||3,192|3,192| |Fixed asset investments|||32,437,175|32,437,175| |Current assets||45,432|5,844,325|5,889,757| |Creditors|due within one year||(10,752,235)|(10,752,235)| |Total||45,432|46,836,183|46,681,615| |Analysis|of net assets between funds - prior year|||| |||Restricted|Unrestricted|Total| |||iunds|funds|funds| |||2022|2022f|2022f| |Tangible|fixed assets||»,028,987|11,028,987| |Intangible|fixed assets||11,734|11,734| |Fixed asset investments|||31,928,373|31,928,373| |Current assets||876,t32|2,975,807|3,851,939| |Creditors|due within one year||(2400,528)|(2,400,528)| |Total||876,132|43,542,373|44,418,505| ## ## ## ## ## ## ## ||||||C0
L '
Ol
'0 '0
Ql '0 0
NC
C"o0|Ol
lo
M
Ql 0
Ol||N
Ql
Ol
Ol
Ed
4IZ|W||CV|CEI Cd
OE|| |---|---|---|---|---|---|---|---|---|---|---|---|---|---| ||||||«D
C'0|»0
0CI
Cl
0%»0
0
0
0
OOO
OOO||Io
0|Id
e|W||ED CO
ED ID
E
ICI OE CD
Cd O ED
CO EO|| ||||||0Z|||no|||||| ||||||00 N
N e
N
0 e|NC'00
L ?'?'
C L L
YI ld 'S
00 0||Ol
ldC|W||EP
CEI
O
ID|Io CI Dl
ID Ol O
Cd ID
E
OC
OO
ICI
Pl 0-|| |I-
EJI0
IC
Ul0
0|e
e
FO|CJI OI
ZO
LU C4
Zz
Ul0
I- IC
~ N.'
CJI &|||Id
CL0C
CL
0
4I0
K0
4I
Ol
CD
ID
COeC
N
0
Ql0|Ql
Ql
» «D»»
e
C
C L C
Ia N
N
N
N
n. 4 n. n. «L
E
oC E E E
0—000
0
Ed 0 0 O
E C C C
eoeee
N
Ed 4! N
C..C n. n. n.
N»O!
N
Ed C
N
N 4!
Ql
CL Qt
ID e
4!
EEEEE
eoeee
IJJ 8 CIJ III EJJ||4I
E00C|W||E
CEI
E-
CD
ID|IDCQOI
0
Dl OI
Cd
Cd Cd CO
IO CO ID
ID ID|| |III
CC
CDI-
(g
Ie|e
E
C
al
0|~
CO
—0
O IU
Z0
+z
Z IU
4 IC
UI 04
Z UJ
I-»
0 LU
I- Z|||C
al
CLOI
E E
0 C|'EI'
0&
CD
CD
CEI
I
CD ao
CE O
Ol IA IA
a! CD CD
I
ED CP
O|||||||| |X
UJ
UI
CJI
LU||CD
I
IU IC
I-0
0 U.
Z||C
Idn.
E0O
dl
0
EO
C3)
0!
Ql
1D||ED
E
Ql
0
'0
'0
Ql
e—
—E
Eze
OlC
~ oO
a! Ed
ID
0
~oo
ID 0
NOO
0 0|ID0
Ndl
Ql
EO
ID
al||||'0
'0
Ql
Ql-E
Ez
OlC
ldoo OO
Ed
N
0
E e
«L '
OO
O»»
e c
ID
ID
0
0 0||| ||||al
10
Ol
N
N
0C
i
4|Ql
dl
0
E
0
0
C|Z|Ql
0
IL
Ol
LL
M
IDZ
e
Xe
Ol
EO
LU
Ql
ID
ID
0odd
al 0 0
JD IL LL
EcZ
0« «nm
~e LL IL
IO
M
EO'g 0 e
ZCD Z Z
ol! 0!!
X X
X 4I
Ql
e N
ro
N
ol
EO
M|IO
JD
Ne
0
EO
ED
a!0CN
dl
C|IOe
E
e|||ED 0 dl
0C22
0 N
LL 0 0 0
JD LL LL
P
C C
O «0
LL
LL LL
N
N
Eo
zCeee
Z Z
N
ML ~~
X X X X
Ql
Ql
N
EO
N
EO
LU LU UJ
LU||N
0
Ql
C|